Ingo G.H. Schmidt‐Wolf

14.4k total citations · 1 hit paper
248 papers, 10.4k citations indexed

About

Ingo G.H. Schmidt‐Wolf is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ingo G.H. Schmidt‐Wolf has authored 248 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 105 papers in Immunology and 75 papers in Molecular Biology. Recurrent topics in Ingo G.H. Schmidt‐Wolf's work include Immune Cell Function and Interaction (64 papers), Immunotherapy and Immune Responses (57 papers) and CAR-T cell therapy research (51 papers). Ingo G.H. Schmidt‐Wolf is often cited by papers focused on Immune Cell Function and Interaction (64 papers), Immunotherapy and Immune Responses (57 papers) and CAR-T cell therapy research (51 papers). Ingo G.H. Schmidt‐Wolf collaborates with scholars based in Germany, United States and China. Ingo G.H. Schmidt‐Wolf's co-authors include Gabriele Schmidt‐Wolf, Janice Dutcher, Gary R. Hudes, Erhan Gökmen, Stephanie Lustgarten, Robert J. Motzer, Vladimir Lesovoy, Robert A. Figlin, Piotr Tomczak and Anil Kapoor and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ingo G.H. Schmidt‐Wolf

241 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

2007 2.8k citations Ingo G.H. Schmidt‐Wolf et al. profile →

Peers

Ingo G.H. Schmidt‐Wolf

ONCOL

IMMUN

PRM

Marco Chilosi Italy

Bruce A. Woda United States

Mitsune Tanimoto Japan

Katsuyuki Aozasa Japan

Christian Peschel Germany

Gilbert Lenoir France

Hans Tesch Germany

Luca Mazzucchelli Switzerland

Jean‐François Emile France

Claudio Tripodo Italy

Marco Chilosi Italy

Ingo G.H. Schmidt‐Wolf

2.8k ×0.7

3.5k ×0.9

ONCOL

2.8k ×1.0

IMMUN

4.9k ×1.7

PRM

1.1k ×0.7

Citations per year, relative to Ingo G.H. Schmidt‐Wolf Ingo G.H. Schmidt‐Wolf (= 1×) peers Marco Chilosi

Countries citing papers authored by Ingo G.H. Schmidt‐Wolf

Since Specialization

Citations

This map shows the geographic impact of Ingo G.H. Schmidt‐Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo G.H. Schmidt‐Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo G.H. Schmidt‐Wolf more than expected).

Fields of papers citing papers by Ingo G.H. Schmidt‐Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo G.H. Schmidt‐Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo G.H. Schmidt‐Wolf. The network helps show where Ingo G.H. Schmidt‐Wolf may publish in the future.

Co-authorship network of co-authors of Ingo G.H. Schmidt‐Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo G.H. Schmidt‐Wolf. A scholar is included among the top collaborators of Ingo G.H. Schmidt‐Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo G.H. Schmidt‐Wolf. Ingo G.H. Schmidt‐Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuzhen, et al.. (2024). Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives. Experimental Hematology and Oncology. 13(1). 45–45. 20 indexed citations

Dakal, Tikam Chand, Ravi Bhushan, Caiming Xu, et al.. (2024). Intricate relationship between cancer stemness, metastasis, and drug resistance. SHILAP Revista de lepidopterología. 5(10). e710–e710. 29 indexed citations

Müller, Paula, Ingo G.H. Schmidt‐Wolf, Sebastian Schaaf, et al.. (2024). Monocyte derived large extracellular vesicles in polytrauma. SHILAP Revista de lepidopterología. 3(9). e70005–e70005. 1 indexed citations

Wang, Yulu, Amit Sharma, Ulrich Jaehde, et al.. (2023). Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients. Frontiers in Genetics. 14. 1218276–1218276. 3 indexed citations

Wang, Yulu, Hongde Liu, Tikam Chand Dakal, et al.. (2022). Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma. Biology. 11(8). 1174–1174. 9 indexed citations

Sharma, Amit, Yulu Wang, Tikam Chand Dakal, et al.. (2022). Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma. Frontiers in Oncology. 12. 1026153–1026153. 6 indexed citations

Vogt, Annabelle, Farsaneh Sadeghlar, Robert Mahn, et al.. (2021). Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma. Cancers. 13(13). 3375–3375. 21 indexed citations

Sharma, Amit, Tikam Chand Dakal, Hongde Liu, et al.. (2021). PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ–DNMT1 Interactions in the Genome. Cancers. 13(16). 3993–3993. 4 indexed citations

Futalan, Diahnn, et al.. (2011). Effect of Oxygen Levels on the Physiology of Dendritic Cells: Implications for Adoptive Cell Therapy. Molecular Medicine. 17(9-10). 910–916. 12 indexed citations

10.

Advani, Anjali S., Bertrand Coiffier, Myron S. Czuczman, et al.. (2010). Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study. Journal of Clinical Oncology. 28(12). 2085–2093. 255 indexed citations

11.

Nowak, Michael, Adrian Tun-Kyi, Ingo G.H. Schmidt‐Wolf, et al.. (2010). Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide. PLoS ONE. 5(6). e11311–e11311. 55 indexed citations

12.

Müller, Stefan C., et al.. (2009). Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide. SHILAP Revista de lepidopterología. 1 indexed citations

13.

Popp, Henning D., et al.. (2007). High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. SHILAP Revista de lepidopterología. 2 indexed citations

14.

Schakowski, Frank, Marcus Gorschlüter, Peter Buttgereit, et al.. (2007). Minimal size MIDGE vectors improve transgene expression in vivo.. PubMed. 21(1). 17–23. 31 indexed citations

15.

Schmidt‐Wolf, Ingo G.H., Elisabeth Sievers, Susanne Frank, et al.. (2006). Anti-tumoral capabilities of effector cells after IFN-α or CpG-motif treatment of cocultured dendritic cells. Archivum Immunologiae et Therapiae Experimentalis. 54(6). 403–409. 8 indexed citations

16.

Ziske, Carsten, Srinivas Nagaraj, Angela Märten, et al.. (2004). Retroviral IFN-α Gene Transfer Combined with Gemcitabine Acts Synergistically via Cell Cycle Alteration in Human Pancreatic Carcinoma Cells Implanted Orthotopically in Nude Mice. Journal of Interferon & Cytokine Research. 24(8). 490–496. 5 indexed citations

17.

Palmedo, H., Peter Albers, Ingo G.H. Schmidt‐Wolf, et al.. (2003). Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate. Journal of Clinical Oncology. 21(15). 2869–2875. 109 indexed citations

18.

Buttgereit, Peter & Ingo G.H. Schmidt‐Wolf. (2002). Gene Therapy of Lymphoma. Journal of Hematotherapy & Stem Cell Research. 11(3). 457–467. 9 indexed citations

19.

Lilienfeld‐Toal, Marie von, Oliver Ebert, I. Theuerkauf, Axel Glasmacher, & Ingo G.H. Schmidt‐Wolf. (2001). Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?. Annals of Hematology. 80(10). 611–613. 6 indexed citations

20.

Flieger, Dimitri, et al.. (1999). Enhancement of Antibody Dependent Cellular Cytotoxicity (ADCC) by Combination of Cytokines. Hybridoma. 18(1). 63–68. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact